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Abstract. 264 words 
 
The standard for assessing dietary sodium intake is to measure 24-h urine sodium. On 
average, 93% of daily sodium intake is excreted in 24-h urine. Expense and difficulties in 
obtaining complete 24-h collections have led to the measurement of sodium concentration 
in spot and single void urine samples using predictive equations to estimate 24-h urine 
sodium.  Although multiple predictive equations have been developed, in addition to 
average bias, all the equations overestimate 24-h sodium at lower levels of measured 24-h 
sodium and underestimate 24-h urine sodium at higher measured 24-h sodium.   One of the 
least-biased estimating equations is the INTERSALT equation, which incorporates a spot 
urine creatinine concentration. We hypothesized that differential fractional excretion of 
sodium (derived from a morning void collection) relative to creatinine (FENa) would impact 
the accuracy of the INTERSALT equation in estimating 24-h urine sodium.  In a prospective 
study of 139 adults aged 65 years and over, three sequential morning void and 24-h urine 
samples were examined. There was a significant correlation between increasing FENa and 
the difference between estimated and measured 24-h urine sodium (r=0.358, p<0.01). In 
the lowest quartile of FENa, the INTERSALT equation overestimated 24-h urine sodium, but 
underestimated 24-h urine sodium with greater magnitude in each of the subsequent 
quartiles of FENa.  Differential excretion of sodium relative to creatinine, potentially 
impacted by renal blood flow and hydration, amongst other factors, affected the accuracy of 
the INTERSALT equation. Additional research may refine the INTERSALT and other predictive 




There is increasing interest in utilising spot urine collections to assess population salt intake 
in countries across the world.1 The World Health Organisation (WHO) member states have 
agreed on a voluntary global non-communicable disease (NCD) target for a 30% relative 
reduction in mean population intake of salt, with the aim of achieving a target of less than 5 
grams per day by 2025.2  Accordingly, a number of countries have set population salt 
reduction targets to reduce sodium intake. The gold standard method for the assessment of 
population salt intake is 24-hour urine collection 1,3,4 as it provides a close measure of sodium 
intake. In order to accurately measure the impact of population-wide salt reduction 
strategies within different countries, it is necessary to obtain complete 24-h urine collections 
from a representative sample of people. However, due to the low participation rate, high 
participant burden, and costs associated with conducting complete 24-h urine collections, 
considerable efforts are being made to explore the potential of spot urines to predict the 
mean 24-h urinary sodium output of populations.5,6  
 
Single void and spot urine sample collection is relatively easy to perform and have a low 
subject burden. If population-average daily sodium intake could be derived from single void 
or spot urine collections, this would significantly increase the survey participation rate across 
all groups within a population, potentially increasing the representativeness of the measures 
of sodium intake. A number of predictive equations have been derived in different 
population groups: Kawasaki7, INTERSALT 8 and  Tanaka.9 There is some evidence that the 
INTERSALT equation, using  morning spot urine samples might provide the least biased 
information about the population mean sodium intakes among US adults aged 18-39 years.10  
Furthermore, a recent evaluation of the predictive ability of the estimating equations to 
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accurately estimate mean population salt intake and mean change found that the INTERSALT 
equation was one of the two equations that performed best for the estimation of absolute 
levels of intake. 11 
 
Currently, there are conflicting views on the accuracy and reliability of using spot urine 
collections to assess the average sodium intake of populations, with some studies advocating 
the use of spot collections12-14, some suggesting that they could be useful 8,15 10,11,16,17 and 
others indicating that they do not provide a reliable estimate of 24-h urinary sodium 
excretion of specific populations, e.g. those with kidney disease.4,18 The TRUE consortium, of 
international health and scientific organizations, recently concluded that further research is 
needed to define the role for spot urine sodium estimates of population average 24-h 
sodium excretion and that there is no current role for spot urine sodium to assess individual 
sodium 24-h excretion.4  
 
There are a number of factors that could reduce the predictive ability of the available 
equations to estimate 24-h urine sodium from spot collections.4 We hypothesized that 
variation in excretion of sodium relative to creatinine would impact the accuracy of 
estimation of 24-h urine excretion using the INTERSALT equation. Current formulae for 
converting sodium concentration from spot urine samples to estimates of 24-h urine sodium, 
including the INTERSALT equation, incorporate urine creatinine concentration and assume 
the relationship of sodium to creatinine concentration is a constant. However, urine sodium 
concentration is highly regulated in part as a means to maintain vascular volume and blood 
pressure, by active net reabsorption in the renal tubules when renal blood flow is reduced.4  
Creatinine concentration is variable depending on glomerular filtration rate, muscle mass, 
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ingestion of meat, and some drugs that can interfere with the active secretion of creatinine.4  
Changes in hydration state differentially affect sodium (which is actively reabsorbed in 
dehydration) and creatinine, which is actively secreted.4  The relationship between sodium 
and creatinine excretion is assessed by the fractional excretion of sodium (FENa). Therefore, 
the aim of this study was to examine the impact of FENa on estimates of 24-h urine sodium 
based on the INTERSALT equation as a potential mechanism to enhance the utility of sodium 
urine estimates of sodium intake.  
 
Subjects and Methods 
This is a prospective study using data from a 6-month randomised controlled trials in which 
healthy community dwelling men and women who were aged >65 years, with baseline 
estimated Glomerular Filtration Rate (eGFR) >45 mL/min/1.73m2 were entered into an 
exercise and nutrition intervention referred to as the STEPS study. In brief, STEPS was a 6-
month, two-arm randomised controlled trial where all participants undertook progressive 
resistance training on 3 days per week and half were randomly allocated to consume either 
two 80g servings of lean red meat on their training days or to consume at least one serving 
of carbohydrate food on training days.19 Samples from all participants completing the study 
from all timepoints were utilised and pooled.  Details of the STEPS study protocol and 
results have been previously published, which include details of measurement techniques 
and questionnaires to assess medication use and lifestyle practices. 19   Height, without 
shoes, was measured using a stadiometer to the nearest 0.5 cm. Weight was measured with 
minimal clothing (gowns) using calibrated electronic digital scales (Seca, model 708), to the 
nearest 0.1 kg.  A lifestyle questionnaire was be used to obtain information on education 
background, history of disease(s)/illnesses, falls and fractures, smoking history, current use 
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of medication and dietary supplement use. Information including medication name, dose 
prescribed, and daily quantity taken was be recorded. Information on any alterations to, or 
new, medication prescribed by the participants’ doctors during the study was also be 
collected by research staff via the monthly phone calls.  
 
The study was approved by the Deakin University Human Research Ethics Committee (HREC 
2013-166) and was registered with the Australian and New Zealand Clinical Trial Registry 
(ACTRN12613001153707). 
 
Participants’ 24-h urine, (including a first morning-void urine collected in a separate bottle) 
and blood samples were collected three times during the study (baseline, 3 and 6 months). 
On each occasion, participants delivered their completed urine collections to a local 
pathology centre where they provided a fasting blood sample within 3 hours of collection of 
the first morning void urine collection. Participants were instructed to collect their 24-h 
urine, starting immediately after the first morning void on the day prior to presenting for 
the fasting blood sample.  From that time onwards, all urine passed during the day and 
during the night up until 5 am the following morning was collected into one bottle.  
Thereafter (the first morning void within the 24-h period) was collected in a second bottle 
and its concentrations of sodium, urea, potassium and creatinine were analysed separately. 
The total volume and total electrolytes and creatinine excreted over the 24-h period were 
calculated by summing the results for the two urine collections within the 24-h collection 
period and the morning void collection was used to estimate 24-h excretion of sodium, 
using the Intersalt equation8 and FeNa.  Participants were provided with both verbal and 
detailed pictorial instructions for the collection, together with a recording sheet. 
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Participants recorded the start and end times for their urine collection and reported any 
missed urine during the 24 h collection period. The reported start and finish times of the 
collections were used to calculate total daily excretion with all urinary results standardized 
to a 24 h period.  Participants were advised to cease eating and drinking (apart from plain 
water) from 12 midnight prior to their fasting blood sample, which was drawn between 
8am-10am.  Blood and urine samples were assayed for sodium, creatinine and urea using 
standardised methods, by an Australasian pathology laboratory accredited by the National 
Association of Testing Authorities/Royal College of Pathologists. Urinary sodium and 
potassium concentration were determined using ion-selective electrodes and urinary 
creatinine concentration was determined from the kinetic Jaffe reaction using the Roche 
Cobas 8000 (c701). 
 
Estimated glomerular filtration rate (eGFR) was calculated using the participants’ serum 
creatinine, age and sex. For females with serum creatinine (SCr) ≤ 62 μmol/L: eGFR 
(mL/min/1.73m2 ) = 144  (SCr in μmol/L  0.0113/0.7) 0.329  (0.993) age in years: for 
females with SCr > 62 μmol/L: eGFR (mL/min/1.73m2) = 144  (SCr in μmol/L  0.0113/0.7) 
1.209  (0.993)age in years: for males with SCr ≤ 80 μmol/L: eGFR (mL/min/1.73m2) = 141  
(SCr in μmol/L 0.0113/0.9) 0.411  (0.993) age in years: for males with SCr > 80 μmol/L: 
eGFR (mL/min/1.73m2) = 141  (SCr in μmol/L  0.0113/0.9) 1.209  (0.993). 20  Participants 
were excluded from participating in the study if their eGFR (fasting morning blood sample) 
was <45 mL/min/1.73m2. Normal kidney function classified as eGRF >89 (mL/min/1.73m2), 
mildly reduced 60-89 (mL/min/1.73m2) and moderately reduced 45-59 (mL/min/1.73m2).21  
Fractional excretion of sodium (FENa) is the percentage of the sodium filtered by the kidney 
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which is excreted in the urine relative to creatinine.  FeNa has been used to assess for 
reduced renal blood flow in the presence of acute renal failure. 22  FENa was calculated by 
the following equation: FENa = (serum creatinine (umol/L) x urinary sodium (mmol/L) (from 
morning single void collection) / serum sodium(mmol/L)(collected within 4 hours of single 
void urine collection) x urinary creatinine (umol/L) (from single void collection) x 100. 23 
Predicted sodium  excretion was derived from the sodium concentration obtained from a 
single void (morning collection) using the INTERSALT equation 8, i.e. for men: 23 x (25.46 + 
(0.46 * void sodium mmol/L) - (2.75 * void creatinine mmol/L) - (0.13 x void potassium 
mmol/L) + (4.10 * baseline BMI kg/m2) + (0.26 * baseline age (yrs)), and for women: 23 x (5.07 
+ (0.34 * void sodium mmol/L) - (2.16 * void creatinine mmol/L) - (0.09 x void potassium 
mmol/L) + (2.39 x baseline BMI kg/m2) + (2.35x baseline age) - (0.03 x (baseline age2)).  
 
Statistical Methods 
Data were analysed using STATA/SE 15.1 for Windows (StataCorp LLC).  Descriptive statistics 
were performed for demographic variables with continuous (mean and standard deviation 
(SD)) and categorical variables ((n, proportion (%)). We used mixed models to account for 
repeated biochemical measures at 0, 3 and 6 months in individuals. Multilevel linear 
regression was used with a random intercept term at the participant level. Pearson’s 
correlations were also assessed separately for women and for men, and by thiazide use. 
Bland-Altman plots represented the predicted INTERSALT and measured urinary sodium 
expressed as sodium (mmol/day) as described by published Intersalt equation.8  Data were 
adjusted for repeated measures, with mean bias and limits of agreement at 95% confidence 




The characteristics of the study participants are shown in Table 1. Complete biochemical 
data were available for 150 participants at baseline, 139 at 3 months and 136 at 6 months. 
Urine samples were excluded if classified as under-collected, based on expected minimum 
range for 24-hurinary excretion of creatinine24, or over-collected, if urinary creatinine was 
greater than 3 SD from mean for gender. One sample was excluded from a female with 
urinary creatinine <4 mmol/24-hr; 2 samples from females and 1 sample from a male were 
excluded for urinary creatinine >3 SD above the gender-specific mean. The median 
collection was 24.0 ((IQR): 23.6, 24.8)) hours.  A further 26 samples where participants 
underwent blood sampling >4 hours after final void were also excluded. Therefore, valid 
biochemical data were available for 139 participants at baseline, 126 participants at 3 
months, and 130 participants at 6 months. Valid biochemical data at all three timepoints 
were available for 105 participants.  
 
Of the 139 participants with an average age of 70 years, less than one quarter had normal 
renal function based on eGFR, with the majority having mildly reduced kidney function 
(71%) and less than 5% having moderately reduced function. Just over three quarters of 
participants had FENa values <1%. The 24-hurinary excretion indicated that men had a 32% 
greater excretion of sodium than women, with no other notable differences between 
different subgroups with respect to other measured urinary or serum metabolites (Table 1).   
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Overall, there was a significant correlation between predicted  sodium (mmol/d)(INTERSALT 
equation) and the actual measured sodium excretion over 24 hrs, with no gender difference 
(overall r=0.57, p<0.001, men r=0.58, p<0.001; women r=0.49, p<0.001). There were also 
significant correlations between predicted  sodium (mmol/d)(INTERSALT equation) and the 
measured sodium excretion over 24 hrs in the subgroups taking anti-hypertensive therapy 
and those not, those with normal renal function or impaired function, and those with FENa 
<1% or > 1% (range r=0.45 - 0.59, p<0.001).  
 
There was a significant association between FENa and the difference between estimated 24-
h urine sodium by the INTERSALT equation and that measured in 24-h urine (r=0.36, 
p<0.01). The higher the FENa, the greater the INTERSALT equation underestimated 24-h 
sodium excretion. When assessing the mean 24-h sodium excretion across quartiles of FENa 
(Table 2), the INTERSALT equation overestimated measured 24-h urinary sodium in the 
lowest quartile, and in each higher quartile there was successive larger underestimates of 
24-h sodium by the INTERSALT equation (Figure 1).  There was a significant trend for 
increasing sodium excretion from a mean of 106 mmol/d sodium in quartile 1(Q1) to 172 
mmol/d in Q4 and a similar trend for predicted sodium excretion using the INTERSALT 
equation.   
Of the 48 participants who provided valid urine samples at baseline, 3 months and 6 
months, 46% (22/48) consistently had FENa <1% and 8% (4/48) consistently had FENa >1% 




Consistent with known differences in renal excretion of sodium and creatinine, we found 
that variation in FENa had an impact on the INTERSALT equations prediction of measured 
24-h urine sodium.  At lower end of the distribution of FENa, the INTERSALT equation 
overestimated measured 24-h urine sodium whilst the second to fourth quartile of FENa, 
the INTERSALT equation increasing underestimated of 24-h urine sodium. It is likely the bias 
of other predictive equations will also be impacted by variation in FENa, as all current 
predictive equations also incorporate spot urine creatinine concentrations.  
Our study included older people with some age-related impairment of renal function, but 
most had normal function or mild impairment (average eGFR was 79 mL/min/1.73m2), as 
having an eGRF >45 mL/min/1.73m2 was an exclusion criterion for entry into the study. 
Accordingly, only 4% of samples were classified as moderately impaired renal function 45-59 
(mL/min/1.73m2) and none had values <44 (mL/min/1.73m2).  A recent study conducted in 
2777 chronic kidney disease patients with a median GFR of 56 mL/min/1.73m2 found that 
there was an association between urine urea and sodium excretion.25  The authors then 
developed new predictive equations, based on the Kawasaki, INTERSALT, and Tanaka 
equations, to estimate 24-h urinary sodium excretion from spot urine collections.  The 
equations which then additionally included urea, reduced bias within the limits of 
agreement in Bland-Altman plots.  
 
Accounting for differences in FENa in predictive equations of 24-h urine sodium might 
therefore result in the development of more accurate predictive equations. Procedures to 
standardize FENa (e.g. providing volunteers with standard hydration instructions) before 
collecting spot urine samples might also reduce variation in the predictive ability of 
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equations related to differences in renal excretion in creatinine and sodium caused by 
varying degrees of dehydration (e.g. when fasting or in hot dry environments).  
 
This preliminary study has several limitations. The study was conducted in an older 
population, many of whom had some small degree of impaired renal function, and/or were 
taking medications that influence renal excretion of sodium. Additionally, 32% of the 
samples were derived from participants who were consuming two 80g servings of meat, 
three days per week. Larger servings of meat (225g) at one sitting have been found to 
acutely increase serum creatinine and urinary creatinine. 26  However, although two 80g 
servings of meat have been found to increase 24 hr urinary excretion of urea in a similar 
subject group participating in a similar study, we found that there was no impact on serum 
or urinary creatinine. 27  The calculation of FeNa is based on single serum sodium and 
creatinine values as well the spot urine sodium and creatinine values.  Creatinine and 
sodium, in serum and urine, will fluctuate under independent regulation during a 24-h. 
period.  Hence the calculation of FeNa can only be considered an estimate of the 
relationship of excretion of sodium and creatinine over 24-h.     Our study also excluded 
people with an eGFR < 45ml/min.  Investigating FeNa on estimates of sodium excretion 
using spot samples in people with an eGFR < 45 ml/min would be useful to assess in a 
further study.  
In conclusion, differential excretion of sodium relative to creatinine, as assessed by FeNa, 
appears to alter the capacity of the Intersalt equation to predict 24-h urinary sodium 
excretion from a single void collection. Further study is needed to examine the impact of 
FENa on the currently available predictive equations in healthy populations and under 
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varying environmental conditions likely to affect FENa (e.g. hot dry conditions).  Introducing 
FENa into predictive equations, potentially in combination with urinary urea, should be 
explored as a potential factor which may reduce equation bias when predicting 24-h urinary 
sodium excretion from spot and single void urine collections.    Currently, the role of spot 
urine samples in estimating average population sodium excretion requires more research  
and is recommended not to be used to assess individual sodium excretion.4   Our findings do 
not impact recommendations that further research is needed to define the role for spot 
urine sodium estimates of population average 24-h sodium excretion.4  
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Figure 1a, b, c, d legend 
Bland Altman plots of the difference in predicted salt (Intersalt equation) and measured sodium (24-
h urine) (mmol/24-h), by quartiles Fractional Excretion of Sodium (FENa) as independent variable).  
The horizontal line indicates mean difference between predicted and measured sodium (mmol/24-h) 
and shaded bar denotes 95% limits of agreement.   
a) Quartile 1 of FENa: Mean difference: +8.6 mmol sodium, limits of agreement: -51.9, 58.8 
mmol sodium 
b) Quartile 2 of FENa: Mean difference: -7.4 mmol sodium, limits of agreement: -78.8, 54.7 
mmol sodium 
c) Quartile 3 of FENa: Mean difference: -17.3 mmol sodium, limits of agreement: -89.9, 53.1 
mmol sodium 






  Quartile 1 of FENa 
Mean difference :+8.6 mmol 
Quartile 2 of FENa  
Mean difference: -7.4 mmol 
Quartile 3 of FENa  
Mean difference: -17.3 mmol 
Quartile 4 of FENa 
Mean difference: -33.4 mmol 
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Table 1 Age, anthropometric measurements, use of antihypertensive medication at baseline (mean (95% CI) or n (%)) by medication use 
 
  
  Overall (n=139) Women (n=85) Men (n=54) 
Anti-hypertensive 
medication excl. 
thiazide (n=55)  




medication (n=68)  
Women / Men 61%/38%   
34 (62%) women  
21 (38%) men 
9 (60%) women  
6 (40%) men 
42 (62%) women  
26 (38%) men 
Age (y) 70.4 (69.7, 71.0) 69.7 (69.0, 70.4) 71.5 (70.3, 72.7) 70.6 (69.5, 71.7) 70.4 (68.4, 72.5) 70.1 (69.2, 71.0) 
Height (m) 1.66 (1.64, 1.67) 1.61 (1.59, 1.62) 1.74 (1.72, 1.76) 1.65 (1.63, 1.68) 1.69 (1.63, 1.75) 1.65 (1.63, 1.67) 
Weight (kg) 75.8 (72.8, 78.7) 69.9 (66.6, 73.2) 85.0 (80.4, 89.7) 79.9 (75.1, 84.6) 87.8 (76.3, 99.2) 69.7 (66.2, 73.2) 
BMI (kg/m2) 27.4 (26.6, 28.3) 27.0 (25.9, 28.1) 28.1 (26.8, 29.4) 29.2 (29.7, 30.6) 30.4 (27.8, 32.9) 25.4 (24.4, 26.3) 
FENab 0.80 (0.73, 0.87) 0.77 (0.68, 0.86) 0.84 (0.75, 0.94) 0.83 (0.74, 0.93) 0.82 (0.50, 1.15) 0.76 (0.67, 0.85) 
- <1% 105 (76%) 70 (82%) 35 (65%) 38 (69%) 13 (87%) 54 (79%) 
- ≥1% 34 (24%) 15 (18%) 19 (35%) 17 (31%) 2 (13%) 14 (21%) 
eGFRc 
(mL/min/1.73m2)  
80.2 (78.5, 82.0) 81.4 (79.3, 83.6) 78.4 (75.4, 81.3) 78.3 (75.3, 81.2) 79.5 (72.9, 86.1) 82.0 (79.7, 84.4) 
- Normal kidney 
functiond 
28 (20%) 21 (25%) 7 (13%) 8 (15%) 3 (20%) 17 (25%) 
- Mildly reduced 
kidney functiond 




4 (3%) 2 (2%) 2 (4%) 2 (4%) 1 (7%) 1 (1%) 
ataking both thiazide diuretics and antihypertensive medications at baseline 
bFractional Excretion of Sodium (FENa) = FENa = (serum creatinine (µmol/L) x urinary sodium (mmol/L) (from morning void collection)/serum 
sodium(mmol/L) x urinary creatinine (µmol/L) (from morning void collection) x 100 
cestimated glomerular filtration rate 




Table 2 Subject characteristics and sodium excretion (Mean (95% CI)) by quartile of Fractional Excretion of Sodium (FENa) 
 FENaa 
Quartile 1  
(n=99) 
(0.17 - <0.54) 
Quartile 2  
(n=99) 
(≥0.54 - <0.74) 
Quartile 3 
 (n=99) 
(≥0.74 – <1.00) 
Quartile 4  
(n=98) 
(≥1.00 - <2.80) 
P value 
for trend 
Women (n (%)) 68 (68.7%) 64 (64.7%) 61 (61.6%) 51 (52.0%) 0.099 
Age (y) 70.9 (70.2, 71.6) 70.9 (70.2, 71.6) 71 (70.3, 71.6) 70.9 (70.2, 71.5) 0.797 
No antihypertensive 
medication 
39 (56.5%) 32 (47.8%) 30 (45.5%) 29 (43.9%) 0.460 
Height (m) 1.65 (1.64, 1.67) 1.65 (1.64, 1.67) 1.65 (1.64, 1.67) 1.66 (1.64, 1.67) 0.072 
Weight (kg) 76.1 (73.2, 79) 75.9 (73, 78.8) 75.5 (72.6, 78.4) 75.6 (72.7, 78.5) 0.344 
24-h salt excretionb g/d 6.3 (5.9, 6.6) 7.9 (7.6, 8.3) 8.9 (8.5, 9.4) 9.7 (9.2, 9.4) <0.0001 
Sodium excretion 
mmol/day 
106.3 (96.1, 116.4) 133.7 (124, 143.3) 150.5 (140.9, 160) 172.1 (161.9, 182.3) <0.0001 
Predicted sodium 
excretionb mmol/d  
 114.8 (107.9, 121.7)  126.3 (119.5, 133.1) 
 
133.2 (126.3, 140.0) 
 
 
138.7 (131.8, 145.6) 
 
<0.0001 
Difference between 24h 
Sodium excretion & 
predicted sodium 
excretion mmol/d  
8.6 (2.8, 14.4) -7.4 (-13.2, -1.6) -17.3 (-23.1, -11.5) -33.4 (-39.2, -27.6) <0.0001 
Creatinine mmol/day 10.6 (10, 11.2) 10.9 (10.3, 11.5) 11 (10.4, 11.6) 10.9 (10.2, 11.5) 0.560 
Urea mmol/d 382.7 (358.6, 406.8) 406.9 (383.9, 429.8) 423.9 (401.2, 446.6) 416.5 (392.3, 440.7) 0.032 
Urinary volume ml/d 1886 (1738, 2034) 2041 (1900, 2183) 2084 (1944, 2223) 2201(2053, 2350) 0.006 
FENaa 0.41 (0.38, 0.45) 0.65 (0.62, 0.69) 0.87 (0.84, 0.91) 1.31 (1.27, 1.34) <0.0001 
- <1% 99 (100%) 99 (100%) 99 (100%) 1 (1.0%) <0.0001 
eGFRc mL/min/1.73m2 80.6 (77.9, 83.2) 79.1 (76.9, 81.2) 76.4 (73.6, 79.2) 75.1 (71.7, 78.5) 0.297 
aFractional Excretion of Sodium (FENa) = FENa = (serum creatinine (µmol/L) x urinary sodium (mmol/L) (from morning void collection) / serum sodium(mmol/L) 
x urinary creatinine (µmol/L) (from morning void collection) x 100 
bMixed linear regression with participant ID as the random effect, and main model was dependent variable 24-h sodium and independent variable was quartiles 
of FENa cEstimated glomerular filtration rate20 
 
